Evidence map›Paper›PMID 38348178›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Neurofilament light chain concentration mediates the association between regional medial temporal lobe structure and memory in adults with Down syndrome.

Natalie DiProspero, Mithra Sathishkumar, John Janecek, Anna Smith, Liv McMillan, Melissa Petersen, Nicholas Tustison, David B Keator, Eric Doran, Christy L Hom and 12 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Blood-based biomarkers for Alzheimer's disease in Down syndrome: A systematic review and meta-analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Article
  4. Alzheimer's Disease Research Center Down Syndrome Cores: Experience from two sites.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Natalie DiProsperoDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
Mithra SathishkumarDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
John JanecekDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
Anna SmithDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
Liv McMillanDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
Melissa PetersenInstitute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA.
Nicholas TustisonDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
David B KeatorDepartment of Psychiatry and Behavioral Sciences School of Medicine University of California Irvine California USA.
Eric DoranDepartment of Pediatrics School of Medicine University of California Irvine California USA.
Christy L HomDepartment of Pediatrics School of Medicine University of California Irvine California USA.
Dana NguyenDepartment of Pediatrics School of Medicine University of California Irvine California USA.
Howard AndrewsDepartment of Psychiatry College of Physicians and Surgeons Columbia University New York New York USA.
Sharon Krinsky-McHaleDepartment of Neurology College of Physicians and Surgeons Columbia University New York New York USA.
Adam M BrickmanDepartment of Neurology College of Physicians and Surgeons Columbia University New York New York USA.
H Diana RosasDepartment of Neurology Massachusetts General Hospital Boston Massachusetts USA.
Florence LaiDepartment of Neurology Massachusetts General Hospital Boston Massachusetts USA.
Elizabeth HeadCenter for the Neurobiology of Learning and Memory University of California Irvine California USA.
Mark MapstoneCenter for the Neurobiology of Learning and Memory University of California Irvine California USA.
Wayne SilvermanDepartment of Pediatrics School of Medicine University of California Irvine California USA.
Ira T LottDepartment of Pediatrics School of Medicine University of California Irvine California USA.
Sid O'BryantInstitute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA.
Michael A YassaDepartment of Neurobiology and Behavior School of Biological Sciences University of California Irvine California USA.
University of California, Irvine · USColumbia University · USMassachusetts General Hospital · USUniversity of North Texas · USIrvine University · USUniversity of Virginia · US

Funding

Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, JOSEPH HYUNGWOO · 2020 to 2025
$103.7M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PHILIP L DE JAGER · 2020 to 2026
$30.1M
Biomarkers of Alzheimer's Disease in Adults with Down SyndromeU01AG051412 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOTT, IRA T., SCHUPF, NICOLE · 2015 to 2019
$26.3M
Neuroimaging biomarkers for cognitive decline in elderly with amyloid pathologyR01AG053555 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Michael A Yassa · 2017 to 2026
$17.0M
NCATS NIH HHS UL1 TR001414NIA NIH HHS P30 AG066462NIA NIH HHS R01 AG053555NIA NIH HHS U01 AG051412NIA NIH HHS U19 AG068054
6 · The paper itself

Abstract

introductionVirtually all people with Down syndrome (DS) develop neuropathology associated with Alzheimer's disease (AD). Atrophy of the hippocampus and entorhinal cortex (EC), as well as elevated plasma concentrations of neurofilament light chain (NfL) protein, are markers of neurodegeneration associated with late-onset AD. We hypothesized that hippocampus and EC gray matter loss and increased plasma NfL concentrations are associated with memory in adults with DS.

methodsT1-weighted structural magnetic resonance imaging (MRI) data were collected from 101 participants with DS. Hippocampus and EC volume, as well as EC subregional cortical thickness, were derived. In a subset of participants, plasma NfL concentrations and modified Cued Recall Test scores were obtained. Partial correlation and mediation were used to test relationships between medial temporal lobe (MTL) atrophy, plasma NfL, and episodic memory.

resultsHippocampus volume, left anterolateral EC (alEC) thickness, and plasma NfL were correlated with each other and were associated with memory. Plasma NfL mediated the relationship between left alEC thickness and memory as well as hippocampus volume and memory. DISCUSSION: The relationship between MTL gray matter and memory is mediated by plasma NfL levels, suggesting a link between neurodegenerative processes underlying axonal injury and frank gray matter loss in key structures supporting episodic memory in people with DS.

Indexed as

Alzheimer's diseaseanterolateral entorhinal cortexcognitive declinedementiaDown syndromeepisodic memoryhippocampusmedial temporal lobemild cognitive impairment

Identifiers

PMID38348178
PMCPMC10859879
OpenAlexW4391758381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.